Header Logo

Connection

MARIA SUAREZ-ALMAZOR to Severity of Illness Index

Back to Details
This is a "connection" page, showing publications MARIA SUAREZ-ALMAZOR has written about Severity of Illness Index.
MARIA SUAREZ-ALMAZOR
Connection Strength
1.159
Severity of Illness Index
  1. Use of the Patient-generated Index in systemic sclerosis to assess patient-centered outcomes. J Rheumatol. 2013 Aug; 40(8):1337-43.
    View in: PubMed
    Score: 0.218
  2. The symptom burden index: development and initial findings from use with patients with systemic sclerosis. J Rheumatol. 2010 Aug 01; 37(8):1692-8.
    View in: PubMed
    Score: 0.177
  3. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors. Support Care Cancer. 2020 Dec; 28(12):6159-6173.
    View in: PubMed
    Score: 0.090
  4. Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis. J Rheumatol. 2019 09; 46(9):1164-1167.
    View in: PubMed
    Score: 0.081
  5. Low disease activity state in rheumatoid arthritis: concepts and derivation of minimal disease activity. Clin Exp Rheumatol. 2006 Nov-Dec; 24(6 Suppl 43):S-52-9.
    View in: PubMed
    Score: 0.069
  6. Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence. Arthritis Rheum. 2013 Jun; 65(6):1421-9.
    View in: PubMed
    Score: 0.054
  7. Psychosocial determinants of outcomes in knee replacement. Ann Rheum Dis. 2011 Oct; 70(10):1775-81.
    View in: PubMed
    Score: 0.048
  8. Development and validation of a case ascertainment tool for ankylosing spondylitis. Arthritis Care Res (Hoboken). 2010 Jan 15; 62(1):19-27.
    View in: PubMed
    Score: 0.043
  9. (Mis)understanding in patient-health care provider communication about total knee replacement. Arthritis Rheum. 2009 Jan 15; 61(1):100-7.
    View in: PubMed
    Score: 0.040
  10. Development and preliminary psychometric testing of a new OA pain measure--an OARSI/OMERACT initiative. Osteoarthritis Cartilage. 2008 Apr; 16(4):409-14.
    View in: PubMed
    Score: 0.038
  11. OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. J Rheumatol. 2007 Jun; 34(6):1432-5.
    View in: PubMed
    Score: 0.036
  12. Development and validation of a preference weight multiattribute health outcome measure for rheumatoid arthritis. J Rheumatol. 2006 Dec; 33(12):2409-11.
    View in: PubMed
    Score: 0.034
  13. Minimal disease activity for rheumatoid arthritis: a preliminary definition. J Rheumatol. 2005 Oct; 32(10):2016-24.
    View in: PubMed
    Score: 0.032
  14. Valuation of arthritis health states across ethnic groups and between patients and community members. Med Care. 2005 Sep; 43(9):921-8.
    View in: PubMed
    Score: 0.032
  15. Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol. 2005 May; 32(5):913-9.
    View in: PubMed
    Score: 0.031
  16. Outcomes Reported in Prospective Long-Term Observational Studies and Registries of Patients With Rheumatoid Arthritis Worldwide: An Outcome Measures in Rheumatology Systematic Review. Arthritis Care Res (Hoboken). 2021 05; 73(5):649-657.
    View in: PubMed
    Score: 0.024
  17. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity. Support Care Cancer. 2020 Dec; 28(12):6145-6157.
    View in: PubMed
    Score: 0.022
  18. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors. Support Care Cancer. 2020 Dec; 28(12):6129-6143.
    View in: PubMed
    Score: 0.022
  19. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors. Support Care Cancer. 2020 Dec; 28(12):6119-6128.
    View in: PubMed
    Score: 0.022
  20. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities. Support Care Cancer. 2020 Dec; 28(12):6175-6181.
    View in: PubMed
    Score: 0.022
  21. OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group. J Rheumatol. 2011 Aug; 38(8):1765-9.
    View in: PubMed
    Score: 0.012
  22. Assessing quality of sleep in patients with rheumatoid arthritis. J Rheumatol. 2009 Sep; 36(9):2077-86.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.